VEGFA and familial dilated cardiomyopathy: The isoform VEGF-B167, delivered as a transgene encapsidated into adeno-associated viruses 9 (AAV-9), has proved an effective therapy to treat DCM, halting the progression of the disease in experimental pre-clinical studies in rodents and dogs [8,19,20].